Ключевые слова:
chronic heart failure; cardiorenal syndrome; syndecan-1; endothelial glycocalyx; cystatin C; renal dysfunction; NT-proBNP; biomarkers.Библиографические ссылки
1. Adingwupu OM, Barbosa ER, Palevsky PM, et al. Cystatin C as a GFR estimation marker in acute and chronic illness: A systematic review. Kidney Medicine. 2023;5:100727.
2. Bhattad VB, et al. Cardiorenal syndrome in heart failure with preserved ejection fraction: insights into pathophysiology and recent advances. Cardiorenal Med. 2025;15:41–60. doi:10.1159/ 000542633.
3. Bozkurt B, Coats AJ, Tsutsui H, Abdelhamid M, Adamopoulos S, Albert N, Anker SD, Atherton J, Böhm M, Butler J, Drazner MH, Felker GM, Filippatos G, Fonarow GC, Fiuzat M, Gomez-Mesa JE, Heidenreich P, Imamura T, Januzzi J, Jankowska EA, Khazanie P, Kinugawa K, Lam CSP, Matsue Y, Metra M, Ohtani T, Francesco Piepoli M, Ponikowski P, Rosano GMC, Sakata Y, SeferoviĆ P, Starling RC, Teerlink JR, Vardeny O, Yamamoto K, Yancy C, Zhang J, Zieroth S. Universal Definition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail. 2021 Apr;27(4):387-413. doi: 10.1016/j.cardfail.2021.01.022. Epub 2021 Mar 1. PMID: 33663906.
4. Chung EYM, Sato Y, Sayer G, Uriel N, Takeda K. Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics. Frontiers in Cardiovascular Medicine. 2022;9:868658. doi:10.3389/fcvm.2022.868658.
5. Ćurko-Cofek B, Jenko M, Taleska Stupica G, Batičić L, Krsek A, Batinac T, Ljubačev A, Zdravković M, Knežević D, Šoštarič M, Sotošek V. The Crucial Triad: Endothelial Glycocalyx, Oxidative Stress, and Inflammation in Cardiac Surgery-Exploring the Molecular Connections. Int J Mol Sci. 2024 Oct 10;25(20):10891. doi: 10.3390/ijms252010891. PMID: 39456673; PMCID: PMC11508174.
6. Eugene Braunwald, From cardiorenal to cardiovascular–kidney–metabolic syndro-mes, European Heart Journal, Volume 46, Issue 8, 21 February 2025, Pages 682–684, https:// doi.org/10.1093/eurheartj/ehae775
7. Foote C.A., Uchimido R., Schmidt E.P. Endothelial Glycocalyx. Physiol Rev. 2022; 102:147–196;
8. Inoda A., et al. Glycocalyx Shedding as a Clinical Biomarker in Critical Illness. Curr Opin Crit Care. 2024.
9. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(Suppl 4):S1–S314.
10. Kim YH, Kitai T, Morales R, Kiefer K, Chaikijurajai T, Tang WHW. Usefulness of Serum Biomarkers of Endothelial Glycocalyx Damage in Prognosis of Decompensated Patients with Heart Failure with Reduced Ejection Fraction. Am J Cardiol. 2022 Aug 1;176:73-78. doi: 10.1016/j.amjcard.2022.04.036. Epub 2022 May 20. PMID: 35606171.
11. Lagrange J, Jahangiri M, Baudry G, et al. Updates on the endothelial glycocalyx in heart failure with preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2025 Oct 10;329(5):H1316-H1330. doi: 10.1152/ajpheart.00410.2025.
12. Levin A, et al. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: Executive Summary. Kidney International. 2024; 105(4):687–701.
13. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2021;42(36):3599–3726.]
14. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al.; ESC Scientific Document Group. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37):3627–3639. doi:10.1093/ eurheartj/ehad195.
15. Miftode R.S., Costache I.I., Petris A.O., et al. Syndecan-1: From a Promising Novel Cardiac Biomarker to a Potential Therapeutic Target in Heart Failure. Life. 2023;13:898;
16. Wadowski PP, et al. Glycocalyx disintegration is associated with mortality in chronic heart failure. J Clin Med. 2025;14:3571. doi:10.3390/jcm14103571.
17. Y A R A Knany, S A F A Kinaneh, F A D E L Bahouth, Z A I D Abassi, Z Azzam, Restoration of endothelial glycocalyx is a promising therapeutic approach for heart failure, European Heart Journal, Volume 46, Issue Supplement_1, November 2025, ehaf784.4741, https://doi.org/10.1093/ eurheartj/ehaf784.4741
18. Yuan X, Jia M, Zhou L, Hou G, Zhang B, Ouyang X, Huang Y. The endothelial glycocalyx: The first line of defense in the prevention and treatment of kidney diseases. Kidney Med. 2025;7(11):101122. doi:10.1016/j.xkme.2025.101122.;
